Published on New York State Department of Health, Wadsworth Center (https://wadsworth.org)

Navigate BioPharma Services Inc

Project ID
50354
Facility Name
Navigate BioPharma Services Inc
Analyte
B-cell acute lymphoblastic leukemia (B-ALL), minimal residual disease (MRD) detection (8-color) - for clinical trial
Method
flow cytometry
Specimen Type
peripheral blood: heparinized; bone marrow: heparinized
Permit Category
Cellular Immunology - Malignant Leukocyte Immunophenotyping
Status
Approved
Facility State
CA
Facility ID
8983